Irritable Bowel Syndrome Trial, Recruiting (NCT06923800)

Irritable Bowel Syndrome Trial, Recruiting NCT06923800 Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06923800 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been formally diagnosed with both Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM), confirmed using standard medical guidelines.
Your IBS symptoms are rated as moderate to severe, based on a standard IBS symptom scoring system (confirm with trial site).
You are a man or woman between 30 and 65 years old.
Your body weight falls within a healthy to normal range — specifically, your BMI (a measure of weight relative to height) is between 18.5 and 29.9.

Who may not be able to join:

You have serious heart, liver, neurological, psychiatric, or other digestive/gut conditions beyond IBS.
You are unable or unwilling to stop taking medications or treatments you currently use to manage your IBS or Fibromyalgia symptoms during the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390804994653

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06923800

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: +390804994653

More information: https://clinicaltrials.gov/study/NCT06923800

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been formally diagnosed with both Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM), confirmed using standard medical guidelines.
Your IBS symptoms are rated as moderate to severe, based on a standard IBS symptom scoring system (confirm with trial site).
You are a man or woman between 30 and 65 years old.
Your body weight falls within a healthy to normal range — specifically, your BMI (a measure of weight relative to height) is between 18.5 and 29.9.

Who may not be able to join:

You have serious heart, liver, neurological, psychiatric, or other digestive/gut conditions beyond IBS.
You are unable or unwilling to stop taking medications or treatments you currently use to manage your IBS or Fibromyalgia symptoms during the trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

Registry

ClinicalTrials.gov

Start date

14 April 2025

Est. completion

1 September 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Fibromyalgia symptom assesment; IBS symptoms assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov